Stay updated on Pembrolizumab Combo in Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Triple Negative Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing nine study sites across Kansas, Missouri, and Texas, replacing the previous state-specific sections (Kansas Locations, Missouri Locations, Texas Locations). The page revision updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T22:31:40.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Updated UI text to indicate PubMed publications are automatically filled and may not pertain to the study, and changed the revision label from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:36.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The government funding lapse and NIH operating status banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:13:40.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The screenshots show only minor formatting and layout adjustments to the study page; core details such as title, conditions, interventions, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:04:29.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    - Added a government operating status notice and links to cc.nih.gov and opm.gov. - Bumped revision from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-06T05:35:52.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:05:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Triple Negative Breast Cancer Clinical Trial page.